Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to enable interim analysis, with guidance for trial size adaptation or futility expected by the end ...

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.

Developed by Ascentage Pharma, olverembatinib is the first China -approved third-generation BCR:ABL1 inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent ...

Nomlabofusp program update expected mid-December to include available safety, pharmacokinetic (PK) and frataxin data, as well ...

A Tullamore man has been imprisoned for one month with hard labour, under the Defence of the Realm Act, for tearing down recruitment posters in his home tome. Aloysius Brennan from Church Street ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Fewer than 20 uncommitted prospects remain in the ESPN 300, but some recent movement on the recruiting trail paired with updated player rankings caused a shake-up in the class rankings.

We can probably chalk up Snell’s performance on this survey to a disappointing MGS Ball Lab result. Behind the scenes, the company is trying to reestablish itself as a DTC leader after TaylorMade’s ...

The last few years have seen MG become a maker of perfectly sensible, well-priced but rather dull electric cars. However, the MG4 EV changed all that by becoming one one of the very best next ...